Syndax Pharmaceuticals (SNDX) Reports Q2 Loss of $0.47/Share

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 EPS of ($0.47), versus ($440.52) reported last year. Revenue for the quarter came in at $305 thousand, versus $17 thousand reported last year.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Microsoft invests $1.5 bln in Abu Dhabi AI firm G42, takes board seat
• Mercantile Bank (MBWM) Tops Q1 EPS by 20c
• UnitedHealth Group (UNH) Tops Q1 EPS by 29c, Tops on Revenue; Offers FY24 EPS Guidance